• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.英国全科医疗中两种心房颤动筛查方法的随机试验。
Br J Gen Pract. 2002 May;52(478):373-4, 377-80.
2
Effectiveness of systematic screening for the detection of atrial fibrillation.系统性筛查用于检测心房颤动的有效性。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD009586. doi: 10.1002/14651858.CD009586.pub2.
3
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.一项针对65岁及以上人群检测心房颤动的系统筛查(针对性筛查和全人群筛查)与常规做法的随机对照试验及成本效益研究。SAFE研究。
Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400.
4
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.心房颤动的筛查策略:系统评价与成本效益分析
Health Technol Assess. 2017 May;21(29):1-236. doi: 10.3310/hta21290.
5
Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.65岁及以上患者心房颤动检测中的筛查与常规做法:整群随机对照试验
BMJ. 2007 Aug 25;335(7616):383. doi: 10.1136/bmj.39280.660567.55. Epub 2007 Aug 2.
6
Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.在一家普通诊所为65岁及以上每年前往流感疫苗接种门诊的患者筛查心房颤动。
Qual Prim Care. 2013;21(2):131-40.
7
Atrial fibrillation: a comparison of methods to identify cases in general practice.心房颤动:全科医疗中病例识别方法的比较
Br J Gen Pract. 2000 Sep;50(458):727-9.
8
A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732].一项关于65岁以上人群心房颤动检测的系统筛查(针对性筛查和全人群筛查)与常规做法的随机对照试验及成本效益研究:(SAFE)[国际标准随机对照试验编号19633732]
BMC Cardiovasc Disord. 2004 Jul 29;4:12. doi: 10.1186/1471-2261-4-12.
9
Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial.机会性筛查与常规护理在初级保健中检测心房颤动的比较:集群随机对照试验。
BMJ. 2020 Sep 16;370:m3208. doi: 10.1136/bmj.m3208.
10
Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.初级保健医生和解释性诊断软件通过心电图诊断心房颤动的准确性:来自老年人心房颤动筛查(SAFE)试验的数据分析。
BMJ. 2007 Aug 25;335(7616):380. doi: 10.1136/bmj.39227.551713.AE. Epub 2007 Jun 29.

引用本文的文献

1
Screening for Atrial Fibrillation in Stroke Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.预防中风时心房颤动的筛查:随机对照试验的系统评价和荟萃分析
Rev Cardiovasc Med. 2025 Jul 23;26(7):36262. doi: 10.31083/RCM36262. eCollection 2025 Jul.
2
Identifying a Heterogeneous Effect of Atrial Fibrillation Screening in Older Adults: A Secondary Analysis of the VITAL-AF Trial.识别老年人房颤筛查的异质性效应:VITAL-AF试验的二次分析
Circ Cardiovasc Qual Outcomes. 2025 Jul;18(7):e011482. doi: 10.1161/CIRCOUTCOMES.124.011482. Epub 2025 Jun 16.
3
Systematic screening for atrial fibrillation with non-invasive devices: a systematic review and meta-analysis.使用非侵入性设备对心房颤动进行系统筛查:一项系统评价和荟萃分析。
Lancet Reg Health Eur. 2025 Apr 11;53:101298. doi: 10.1016/j.lanepe.2025.101298. eCollection 2025 Jun.
4
Atrial fibrillation screening in Syrian patients reporting to the emergency department during the ongoing conflict: a cross-sectional study.在叙利亚冲突期间前往急诊科就诊的患者中进行房颤筛查:一项横断面研究。
Front Cardiovasc Med. 2025 Feb 20;12:1512558. doi: 10.3389/fcvm.2025.1512558. eCollection 2025.
5
Screening and detection of atrial fibrillation in primary care: current practice and future perspectives.基层医疗中房颤的筛查与检测:当前实践与未来展望。
Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv12-iv18. doi: 10.1093/eurheartjsupp/suae074. eCollection 2024 Jul.
6
PerIoperative iNflammatory reSponse assessment In hiGH-risk patienTs undergoing non-cardiac surgery (INSIGHT): study protocol of a prospective non-interventional observational study.围手术期炎症反应评估在非心脏手术高危患者中的应用(INSIGHT):一项前瞻性非干预性观察研究的研究方案。
BMJ Open. 2023 Jul 19;13(7):e065469. doi: 10.1136/bmjopen-2022-065469.
7
Screening for undiagnosed atrial fibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial.在基层医疗就诊时使用单导联心电图筛查未确诊的心房颤动:来自 VITAL-AF 试验的患者参与度和从业者观点。
BMC Prim Care. 2023 Jun 30;24(1):135. doi: 10.1186/s12875-023-02087-5.
8
Cost-effectiveness of atrial fibrillation screening in Canadian community practice.加拿大社区医疗实践中房颤筛查的成本效益
Heart Rhythm O2. 2022 Nov 17;4(2):103-110. doi: 10.1016/j.hroo.2022.11.003. eCollection 2023 Feb.
9
Sensitivity and specificity of automated blood pressure devices to detect atrial fibrillation: A systematic review and meta-analysis of diagnostic accuracy.自动血压测量设备检测心房颤动的敏感性和特异性:诊断准确性的系统评价和荟萃分析
Front Cardiovasc Med. 2022 Aug 12;9:956542. doi: 10.3389/fcvm.2022.956542. eCollection 2022.
10
Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices.使用可穿戴设备筛查心房颤动的成本效益。
JAMA Health Forum. 2022 Aug 5;3(8):e222419. doi: 10.1001/jamahealthforum.2022.2419. eCollection 2022 Aug.

本文引用的文献

1
Atrial fibrillation: a comparison of methods to identify cases in general practice.心房颤动:全科医疗中病例识别方法的比较
Br J Gen Pract. 2000 Sep;50(458):727-9.
2
Does the frame affect the picture? A study into how attitudes to screening for cancer are affected by the way benefits are expressed.
J Med Screen. 1998;5(3):137-40. doi: 10.1136/jms.5.3.137.
3
Identification of patients with atrial fibrillation in general practice: a study of screening methods.全科医疗中房颤患者的识别:筛查方法研究
BMJ. 1998 Aug 1;317(7154):327-8. doi: 10.1136/bmj.317.7154.327.
4
Screening for atrial fibrillation in primary care.基层医疗中房颤的筛查。
Heart. 1998 Jan;79(1):50-5. doi: 10.1136/hrt.79.1.50.
5
Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views.基层医疗中的华法林抗凝治疗:当前实践及临床医生观点的区域调查
Br J Gen Pract. 1997 May;47(418):309-10.
6
Warfarin in chronic atrial fibrillation.华法林用于慢性心房颤动
Lancet. 1993 May 29;341(8857):1376-7. doi: 10.1016/0140-6736(93)90945-d.
7
Service provision and use of anticoagulants in atrial fibrillation.心房颤动中抗凝剂的服务提供与使用
BMJ. 1995 Aug 26;311(7004):558-60. doi: 10.1136/bmj.311.7004.558.
8
Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.华法林与阿司匹林预防非瓣膜性心房颤动患者卒中的成本效益分析
JAMA. 1995 Dec 20;274(23):1839-45.
9
ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation.心房颤动基础。心房颤动的病史、流行病学及重要性。
BMJ. 1995 Nov 18;311(7016):1361-3. doi: 10.1136/bmj.311.7016.1361.
10
Consultation rates in English general practice.英国全科医疗中的会诊率。
J R Coll Gen Pract. 1989 Feb;39(319):68-72.

英国全科医疗中两种心房颤动筛查方法的随机试验。

Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.

作者信息

Morgan Stephen, Mant David

机构信息

Department of Primary Medical Care, University of Southampton, Aldermoor Health Centre.

出版信息

Br J Gen Pract. 2002 May;52(478):373-4, 377-80.

PMID:12014534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1314292/
Abstract

BACKGROUND

Atrial fibrillation is a common and treatable cause of stroke that often remains unrecognised. Screening has been suggested but there is very little evidence concerning the uptake of screening in the elderly population at risk, nor of the optimal method of screening in a general practice setting

AIM

To compare the uptake and effectiveness of two methods of screening for atrial fibrillation in general practice--systematic nurse-led screening and prompted opportunistic case finding.

DESIGN OF STUDY

Randomised controlled trial.

SETTING

Patients aged 65 to 100 years (n = 3,001) from four general practices within the MRC general practice framework.

METHOD

Each of the four study practices were selected from one quartile, after ranking all framework practices according to the small area standardised mortality ratio of the geographical area served. Patients were randomised either to nurse-led screening or to prompted opportunistic casefinding. The proportion of patients assessed and the proportion found to have atrial fibrillation were compared. The sensitivity and specificity of clinical assessment of pulse are also reported.

RESULTS

Substantially more patients had their pulse assessed through systematic screening by invitation (1,099/1,499 [73%]) than through opportunistic case finding (439/1,502 [29%], difference = 44%, 95% confidence interval [CI] = 41% to 47%). Atrial fibrillation was detected in 67 (4.5%) and 19 (1.3%) patients respectively (difference = 3.2%, 95% CI= 2.0 to 4.4). Invitation to nurse-led screening achieved significantly higher assessment rates than case finding in all practices; however, the proportion of patients assessed in the case-finding arm varied markedly between practices (range = 8% to 52%). The number needed to screen to identify one additional patient with atrial fibrillation was 31 (95% CI = 23 to 50). The proportion of screened patients with atrial fibrillation receiving anticoagulation treatment was 25%, although in the majority (53/65 [82%]) atrial fibrillation had been previously recorded somewhere on their medical record. If the nurse used any irregularity of the pulse as the screening criterion, the sensitivity of screening was 91% and the specificity was 74%; sensitivity fell to 54% but specificity increased to 98% if the criterion used was continuous irregularity.

CONCLUSIONS

Nurse-led screening for atrial fibrillation in UK general practice is both feasible and effective and will identify a substantial number of patients who could benefit from antithrombotic therapy. Although the majority of patients detected at first screening could be identified by careful scrutiny of medical records, review of record summaries was insufficient in the practices involved in this study and screening may be a more cost-effective option.

摘要

背景

心房颤动是一种常见且可治疗的中风病因,但常常未被识别。有人提议进行筛查,但关于高危老年人群筛查的接受情况以及在全科医疗环境中最佳筛查方法的证据非常少。

目的

比较全科医疗中两种心房颤动筛查方法的接受情况和有效性——由护士主导的系统筛查和机会性病例发现。

研究设计

随机对照试验。

研究地点

来自医学研究委员会全科医疗框架内四个全科医疗诊所的65至100岁患者(n = 3001)。

方法

在根据所服务地理区域的小面积标准化死亡率对所有框架诊所进行排名后,从四个四分位数中各选一个研究诊所。患者被随机分配到由护士主导的筛查组或机会性病例发现组。比较接受评估的患者比例和被发现患有心房颤动的患者比例。还报告了脉搏临床评估的敏感性和特异性。

结果

通过邀请进行系统筛查的方式评估脉搏的患者(1099/1499 [73%])比通过机会性病例发现的方式(439/1502 [29%],差异 = 44%,95%置信区间[CI] = 41%至47%)多得多。分别在67例(4.5%)和19例(1.3%)患者中检测到心房颤动(差异 = 3.2%,95%CI = 2.0至4.4)。在所有诊所中,邀请进行由护士主导的筛查的评估率显著高于病例发现;然而,病例发现组中接受评估的患者比例在不同诊所之间差异很大(范围 = 8%至52%)。识别出另外一名心房颤动患者所需的筛查人数为31人(95%CI = 23至50)。接受抗凝治疗的筛查出的心房颤动患者比例为25%,尽管大多数(53/65 [82%])患者的病历中此前已在某处记录有心房颤动。如果护士将任何脉搏不规则作为筛查标准,筛查的敏感性为91%,特异性为74%;如果使用的标准是持续性不规则,则敏感性降至54%,但特异性升至98%。

结论

在英国全科医疗中,由护士主导的心房颤动筛查既可行又有效,将识别出大量可从抗血栓治疗中获益的患者。尽管首次筛查时检测出的大多数患者可通过仔细查阅病历识别出来,但在本研究涉及的诊所中,病历摘要审查并不充分,筛查可能是一种更具成本效益的选择。